Wednesday, October 7th 2015
5:30pm - 7:30pm
A/Prof Pavlakis will present the results of this trial and together with Dr Viive Howell from the Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, will discuss the concept of targeted therapies for cancer treatment and the next phase of this study to identify changes in proteins or DNA that may identify the patients who are most likely to benefit from this new treatment.
Located in Level 5 Auditorium, Kolling Institute, RNSH
At the Kolling, we believe finding the answers together will drive innovation that delivers the most informed healthcare journey.
We are therefore uniting health research with patient care and community wellbeing by developing a co-operative model for discovery that delivers constant innovation across all aspects of health.
The work we do here at the Kolling is about finding tangible solutions to the real world health problems that are impacting our community.
We are making important breakthroughs, identifying new drugs and devices that can
cure disease, and developing smarter ways of diagnosing and treating patients and keeping people healthy.